Travere Therapeutics to report Q2 financial results after US market close
TVTX•Q2 2026 results and conference call scheduled
Travere Therapeutics schedules Q2 2026 results for Aug. 4, 2026, released after the U.S. market close.
Conference call and webcast are set for Aug. 4, 2026 at 4:30 p.m. ET; access via https://ir.travere.com/events-and-presentations.




